Jiuzhitang Co., Ltd. (000989.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 8.68

From 52W high−20.55%

Volume19.88M

Market capCNY 7.41B

P/E (TTM)33.3x

P/S (TTM)3.1x

Div yield3.46%

Key dataSep 21, 2026

Open

CNY 8.68

From 52W high

−20.55%

Volume

19.88M

Market cap

CNY 7.41B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.2x

P/E (TTM)

33.3x

RSI (14)

44.3

MomentumView details →

1D Return

−4.20%

YTD Return

−0.57%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

33.3x

EV/EBITDA

17.2x

EV/Sales

3.1x

P/S (TTM)

3.1x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

60.16%

Net Margin

11.31%

EBITDA Margin

17.90%

ROE (TTM)

7.01%

ROA (TTM)

4.73%

Asset Turnover

0.43x

GrowthView details →

Revenue YoY

+14.27%

EPS YoY

+44.44%

FCF YoY

−10.15%

Revenue CAGR 3Y

−9.76%

EPS CAGR 3Y

−14.32%

EBITDA YoY

—

MomentumView details →

1D Return

−4.20%

YTD Return

−0.57%

1Y Return

−14.57%

RSI (14)

44.3

vs 50D SMA

−4.57%

vs 200D SMA

−2.76%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

2.40x

Quick Ratio

1.76x

Div Yield

3.46%

Div Rate

CNY 0.30

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.40B

Net Income (TTM)

271.01M

Op. CF (TTM)

485.49M

Latest newsMore news →

Jiuzhitang reported a 29.08% revenue increase in the first half of 2026, the highest among the 68 traditional medicine companies, while Zbd Pharmaceutical reported a 58.60% revenue decline, the lowest.21d ago

Jiuzhitang announced its first-half 2026 results: revenue of 1.632 billion yuan, up 29.08% year-on-year; net profit attributable to shareholders of 250 million yuan, up 74.01%; non-GAAP net profit of 232 million yuan, up 70.36%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.33d ago

Similar companies

秋田微300939.SZ 科创新源300731.SZ 世嘉科技002796.SZ 万里扬002434.SZ 可立克002782.SZ 桂林三金002275.SZ Find similar companies →

Latest newsMore news →

Jiuzhitang reported a 29.08% revenue increase in the first half of 2026, the highest among the 68 traditional medicine companies, while Zbd Pharmaceutical reported a 58.60% revenue decline, the lowest.21d ago Jiuzhitang announced its first-half 2026 results: revenue of 1.632 billion yuan, up 29.08% year-on-year; net profit attributable to shareholders of 250 million yuan, up 74.01%; non-GAAP net profit of 232 million yuan, up 70.36%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.33d ago